RECOMBINANT DNA TECHNOLOGY 

NMC CBME Competency (BI 7.4): Describe recombinant DNA technology, its applications, and ethical aspects.

1. INTRODUCTION & DEFINITION

• Definition: Recombinant DNA (rDNA) technology is the process of cutting and joining DNA molecules from different biological sources to create a new, hybrid DNA molecule (recombinant DNA), which is then introduced into a host organism to replicate and express the desired gene.

• Synonyms: Genetic Engineering, Gene Cloning, Gene Splicing.

• Goal: To isolate a specific gene of interest, multiply it, and express it to produce medically or commercially important proteins (e.g., Human Insulin).

2. TOOLS OF rDNA TECHNOLOGY (High-Yield Short Note)

To create recombinant DNA, four essential tools are required:

A. The "Molecular Scissors" (Restriction Endonucleases - RE)

• Function: Enzymes that recognize specific DNA sequences and cut the DNA at or near that site.

• Type II RE: Most commonly used in rDNA technology (e.g., EcoRI, HindIII, BamHI).

• Recognition Site: They recognize Palindromic sequences (sequences that read the same on both strands in the 5' → 3' direction, like "MADAM").

• Types of Cuts:

  • Sticky Ends (Staggered cuts): Produce short, single-stranded overhangs. Ideal for cloning as they easily pair with complementary sticky ends (e.g., EcoRI).

  • Blunt Ends (Even cuts): Produce flat ends. Harder to join but can be linked using specific ligases (e.g., SmaI).

B. The "Vehicles" (Cloning Vectors)

• Definition: DNA molecules used to carry the target DNA into the host cell.

• Essential Features of a Good Vector:

  • Origin of Replication (ori): Allows autonomous replication inside the host.

  • Selectable Marker: Usually an antibiotic resistance gene (e.g., Ampicillin resistance, $Amp^R$) to identify cells that have taken up the vector.

  • Multiple Cloning Site (MCS) / Polylinker: A region containing multiple unique restriction sites for the insertion of foreign DNA.

• Types of Vectors:

  • Plasmids: Extra-chromosomal circular DNA in bacteria (e.g., pBR322). Insert size: up to 10 kb.

  • Bacteriophages: Bacterial viruses (e.g., Lambda phage). Insert size: up to 20 kb.

  • Cosmids: Hybrid of plasmid and phage. Insert size: up to 45 kb.

  • BACs & YACs (Bacterial/Yeast Artificial Chromosomes): For very large DNA fragments (used in Human Genome Project).

C. The "Molecular Glue" (DNA Ligase)

• Function: Joins the isolated target DNA and the vector DNA by forming phosphodiester bonds between the 5'-phosphate and 3'-hydroxyl ends. (Requires ATP).

D. The Host Cell

• Organisms that receive the recombinant DNA and allow it to multiply/express.

• Examples: Escherichia coli (most common), Yeast (Saccharomyces cerevisiae), Mammalian cell lines.

3. STEPS OF rDNA TECHNOLOGY (Classic 10-Mark Essay)

Exam Tip: Always draw a flowchart when answering this question.

Step 1: Isolation of Target DNA (Passenger DNA)

• The DNA containing the gene of interest (e.g., the human insulin gene) is extracted from the donor cell.

• Alternatively, complementary DNA (cDNA) is synthesized from mRNA using the enzyme Reverse Transcriptase (advantageous because it lacks introns).

Step 2: Selection and Cleavage of Vector

• A suitable vector (e.g., plasmid) is chosen.

• Both the target DNA and the vector are cut using the SAME Restriction Endonuclease. This ensures that both DNA molecules have complementary "sticky ends."

Step 3: Ligation (Creation of Chimeric DNA)

• The cut target DNA and cut vector are mixed together.

• DNA Ligase is added to seal the nicks, creating a single recombinant DNA (rDNA) molecule.

Step 4: Introduction into Host Cell (Transformation)

• The rDNA is introduced into a competent host cell (e.g., E. coli).

• Methods of insertion:

  • Chemical method: Calcium chloride ($CaCl_2$) treatment + Heat shock.

  • Physical methods: Electroporation (electric shock), Microinjection, Gene gun.

Step 5: Screening and Selection of Recombinants

• Not all host cells take up the recombinant DNA. We must select the successful ones.

• Antibiotic Resistance Method: Host cells are grown on an agar plate containing an antibiotic (e.g., Ampicillin). Only cells containing the plasmid (which has the $Amp^R$ gene) will survive.

• Blue-White Screening (Insertional Inactivation):

  • The target gene is inserted into the lacZ gene of the plasmid.

  • Successful insertion destroys the lacZ gene (insertional inactivation).

  • Cells are grown on X-gal medium.

  • Non-recombinants (intact lacZ) produce Blue colonies.

  • Recombinants (disrupted lacZ) produce White colonies (These are the ones we want!).

Step 6: Expression and Multiplication

• The selected white colonies are cultured in large-scale bioreactors.

• The host machinery translates the recombinant DNA into the desired protein.

• The protein is then isolated, purified, and formulated (Downstream processing).

4. APPLICATIONS OF rDNA TECHNOLOGY (Crucial for MBBS)

A. Medical Applications (Therapeutic Products)

1. Recombinant Human Insulin (Humulin): Initially, animal insulin caused allergic reactions. Now, A and B chains of human insulin are synthesized separately in E. coli, extracted, and joined by disulfide bonds.

2. Recombinant Vaccines: e.g., Hepatitis B vaccine (produced in yeast by cloning the HBsAg gene). Highly safe as it lacks the viral genome.

3. Human Growth Hormone (Somatotropin): For treating pituitary dwarfism.

4. Tissue Plasminogen Activator (tPA): Used to dissolve blood clots in acute Myocardial Infarction and ischemic stroke.

5. Blood Clotting Factors: Factor VIII for Hemophilia A; Factor IX for Hemophilia B (eliminates the risk of HIV/HCV from donor blood transfusions).

B. Diagnostic Applications

1. Gene Probes: Single-stranded, radio-labeled DNA used to detect specific genetic diseases (e.g., Sickle cell anemia, Thalassemia) via Southern Blotting.

2. Prenatal Diagnosis: Identifying genetic defects in the fetus using chorionic villus sampling or amniocentesis.

3. Viral Diagnosis: Detecting HIV, Hepatitis, and SARS-CoV-2 (Basis of RT-PCR).

C. Gene Therapy

• Replacing a defective gene with a normal, functional gene.

• Classic example: Treatment of SCID (Severe Combined Immunodeficiency) by inserting a functional Adenosine Deaminase (ADA) gene.

D. Forensic Medicine

• DNA Fingerprinting: Uses VNTRs (Variable Number of Tandem Repeats) to identify individuals in paternity disputes or criminal investigations.

5. DNA LIBRARIES (Important 5-Mark Short Essay)

A collection of cloned DNA fragments representing the entire genetic material of an organism.

• Genomic Library: Contains fragments of the entire genome (including introns and exons). Cut by restriction enzymes and cloned.

• cDNA Library (Complementary DNA): Contains only the expressed genes (exons). Made from mRNA using Reverse Transcriptase. Preferred for expressing human proteins in bacteria, because bacteria cannot process (splice) human introns.

6. EXAM CORNER: PYQs & EXPECTED QUESTIONS (KUHS/NMC Pattern)

Long Essays (10 Marks)

Q1. Define Recombinant DNA Technology. Describe the steps involved in gene cloning. Write a note on its medical applications. (Very Common)

• Structure your answer: Definition (1m) → Tools (2m) → Steps with Flowchart (4m) → Medical Applications (3m).

Q2. What are cloning vectors? Describe the steps of Recombinant DNA technology and explain how recombinant Human Insulin is produced.

Short Essays (5 Marks)

Q1. Restriction Endonucleases.

• Key points to include: Definition, Molecular scissors, Type II, Palindromic sequences, Sticky vs Blunt ends, Examples (EcoRI).

Q2. Plasmids and Cloning Vectors.

• Key points to include: Definition, Essential features (Ori, Marker, MCS), pBR322 diagram.

Q3. Differences between Genomic Library and cDNA Library.

• Make a T-table: Introns present vs absent, Source (DNA vs mRNA), Enzyme used (RE vs Reverse Transcriptase), Usefulness in bacterial expression.

Q4. Blue-White Screening (Insertional Inactivation).

• Key points to include: Principle of lacZ gene, X-gal substrate, β-galactosidase enzyme, White colonies = Recombinants.

Short Answers / Reasoning (2 or 3 Marks)

Q1. Why are restriction endonucleases called molecular scissors?

• Ans: Because they cleave the phosphodiester backbone of DNA at highly specific recognition sites, allowing targeted cutting of genetic material.

Q2. Name two therapeutic proteins produced by rDNA technology and their clinical use.

• Ans: 1. Humulin (Diabetes Mellitus), 2. tPA (Myocardial Infarction).

Q3. Why is cDNA used instead of genomic DNA for cloning human genes into bacteria?

• Ans: Human genomic DNA contains introns. Bacteria lack the splicing machinery to remove introns. cDNA is synthesized from mature mRNA (lacks introns), allowing bacteria to directly translate it into the correct functional protein.

Q4. What is a palindromic sequence? Give an example.

• Ans: A DNA sequence that reads the same 5' to 3' on both strands. Example for EcoRI: 5'-GAATTC-3' / 3'-CTTAAG-5'.

💡 Last-Minute Revision Mnemonic for Steps of Cloning: I Saw Cats Licking The Sweet Eggs

1. Isolation

2. Selection of vector

3. Cleavage (Cutting)

4. Ligation

5. Transformation

6. Screening

7. Expression

Lecture Notes on Recombinant DNA Technology

I. Introduction and Central Concept

Recombinant DNA technology, commonly referred to as genetic engineering or molecular cloning, involves the artificial modification of the genetic constitution of a living cell by introducing foreign DNA. The essence of this technology is the isolation, manipulation, and end-to-end joining of DNA sequences from completely different sources (e.g., human and bacterial DNA) to create chimeric or recombinant DNA molecules.

This technology was pioneered in the early 1970s following the discovery of restriction enzymes. In 1972, the molecular biologist Paul Berg performed the world's first successful recombinant DNA experiment by artificially manipulating DNA in a test tube to create a sequence that did not exist in nature.

II. Essential Tools of Recombinant DNA Technology

The successful manipulation of DNA requires a specific biochemical toolkit comprising passenger DNA, specialized enzymes, and cloning vectors.

1. Passenger DNA (Target DNA)

The foreign DNA fragment that is to be passively transferred from one cell into another is known as passenger or insert DNA. This DNA can be obtained through:

• Complementary DNA (cDNA): Synthesized from an mRNA template using the enzyme reverse transcriptase. Because it is derived from processed mRNA, cDNA lacks non-coding introns, making it ideal for expressing eukaryotic proteins in bacterial hosts.

• Synthetic DNA: Short fragments chemically synthesized in the laboratory.

• Random Genomic DNA: Genomic DNA fragmented using restriction enzymes ("shotgun" approach).

2. Key Enzymes

• Restriction Endonucleases (REs): Often called "molecular scissors," these bacterial enzymes cleave double-stranded DNA at highly specific recognition sites. Most restriction enzymes used in cloning (Type II) recognize short palindromic sequences (4–8 base pairs long) that have two-fold rotational symmetry.

  • Nomenclature: Named after the organism of origin. For example, EcoRI comes from Escherichia coli RY13 strain.

  • Cleavage Patterns: They can generate staggered cuts that leave single-stranded, complementary overhangs known as sticky ends (e.g., EcoRI, BamHI), or they can cut straight across to yield blunt ends (e.g., HaeIII, HpaI).

• DNA Ligase: An enzyme that covalently joins DNA fragments by catalyzing the formation of 3' $\rightarrow$ 5' phosphodiester bonds between them, sealing nicks to create the final recombinant molecule.

• Reverse Transcriptase: An RNA-dependent DNA polymerase (originally from retroviruses) that synthesizes a single-stranded DNA molecule from an mRNA template.

• S1 Nuclease: Used to degrade single-stranded DNA and specifically to remove the "hairpin" loops formed during the synthesis of double-stranded cDNA.

3. Cloning Vectors

A vector is a self-replicating DNA molecule used to transport the foreign DNA fragment into a host cell. Essential properties of a vector include the capacity for autonomous replication (origin of replication), at least one unique restriction enzyme recognition site, and a selectable marker (such as an antibiotic resistance gene). Common vectors and their insert capacities:

• Plasmids: Small, circular, extrachromosomal bacterial DNA (e.g., pBR322, pUC19) that can accommodate inserts up to 10 kb.

• Bacteriophages (e.g., Lambda phage): Viruses that infect bacteria. They can accept DNA inserts of 10–20 kb.

• Cosmids: Hybrids of plasmids and phages (containing lambda cos sites) that can accommodate 35–50 kb inserts.

• Artificial Chromosomes: Bacterial (BACs) and Yeast Artificial Chromosomes (YACs) are used for very large DNA inserts. BACs accept 50–250 kb, while YACs can hold 500–3000 kb, making them crucial for mapping whole genomes.

III. The Steps of Molecular Cloning

Molecular cloning is the process of generating multiple identical copies of a specific recombinant DNA molecule in a host cell.

Step 1: Isolation and Preparation of DNA The target gene is isolated (or cDNA is generated), and the cloning vector is purified.

Step 2: Cleavage by Restriction Enzymes Both the vector DNA and the passenger DNA are cut with the same restriction endonuclease. Because the enzyme recognizes the same palindromic sequence on both molecules, it generates perfectly complementary "sticky ends" on both the vector and the target insert.

Step 3: Ligation (Formation of Chimeric DNA) The cut vector and the target DNA fragments are mixed and incubated together under conditions that allow their sticky ends to anneal (base pair). DNA ligase and ATP are added to covalently seal the sugar-phosphate backbone, producing the final recombinant (chimeric) DNA molecule.

• Note on Recircularization: To prevent the vector's sticky ends from simply re-joining without the insert, researchers can use a technique called "homopolymer tailing" or treat the vector with alkaline phosphatase to remove 5'-phosphates.

Step 4: Introduction into Host Cells (Transformation) The recombinant vector must be introduced into a host, typically a rapidly dividing bacterium like E. coli. This process, termed transformation in bacteria (or transfection in eukaryotes), is facilitated by treating the cells with calcium chloride or using a brief electrical shock (electroporation) to make the cell membrane permeable to the large DNA molecules.

Step 5: Selection and Screening of Recombinants Because transformation is inefficient and many host cells will not take up the vector, selection mechanisms are required:

• Antibiotic Selection: Vectors usually carry antibiotic resistance genes (e.g., ampR for ampicillin). Growing the cells on media containing the antibiotic ensures that only cells that took up the plasmid survive.

• Insertional Inactivation / Replica Plating: Some plasmids (like pBR322) carry two resistance genes. If the target DNA is inserted into one of these genes (e.g., the tetracycline resistance gene), that gene is destroyed. Recombinants will thus be resistant to ampicillin but sensitive to tetracycline.

• Blue-White Screening ($\alpha$-complementation): Plasmids with a multiple cloning site inside the lacZ gene are used. If an insert disrupts the lacZ gene, the bacteria cannot produce functional $\beta$-galactosidase and will form white colonies. If no insert is present, the functional enzyme turns a specific substrate (X-gal) blue. Thus, white colonies contain the recombinant DNA.

IV. DNA Libraries

A DNA library is a vast collection of cloned restriction fragments representing the genetic material of an organism.

• Genomic Libraries: Created by randomly digesting the total genomic DNA of an organism and inserting the fragments into vectors. It contains all DNA sequences, including coding regions, non-coding regions, and introns.

• cDNA Libraries: Generated by reverse-transcribing the mRNA population of a specific tissue into cDNA, which is then cloned into vectors. A cDNA library only contains expressed genes and differs depending on the tissue type from which the mRNA was extracted (e.g., pancreatic cells vs. bone marrow).

V. Related Analytical Techniques

1. Probes and Hybridization

A molecular probe is a short, single-stranded piece of DNA or RNA labeled with a radioisotope or fluorescent dye. It has a known sequence and is used to identify a complementary target DNA sequence out of millions of fragments by binding to it via complementary base pairing (hybridization).

2. Blotting Techniques

These are methods used to separate and identify specific macromolecules:

• Southern Blotting: Used for DNA analysis. DNA is digested by restriction enzymes, separated by size on an agarose gel, denatured, and transferred (blotted) onto a nitrocellulose membrane. A labeled probe is then hybridized to the membrane to locate specific DNA sequences.

• Northern Blotting: Used for analyzing RNA to study gene expression. RNA is separated by gel electrophoresis and probed with labeled cDNA or RNA.

• Western Blotting: Used for identifying specific proteins separated on a gel. Labeled antibodies are used as probes instead of nucleic acids.

3. Polymerase Chain Reaction (PCR)

Invented by Kary Mullis, PCR is an in vitro enzymatic method to exponentially amplify specific target DNA sequences without needing host cells. It requires Taq polymerase (a heat-stable DNA polymerase), a pair of specific oligonucleotide primers, dNTPs, and repeated cycles of thermal heating and cooling (denaturation at 94°C, annealing at 45-60°C, and extension at 72°C).

4. Restriction Fragment Length Polymorphism (RFLP)

RFLP analyzes variations in the length of restriction fragments caused by point mutations or polymorphisms that create or destroy a restriction enzyme recognition site. It is clinically valuable for identifying inherited diseases, such as the detection of the sickle cell mutation in the $\beta$-globin gene, which eliminates an MstII restriction site.

VI. Medical and Biological Applications

The applications of recombinant DNA technology are vast and transformative:

1. Production of Therapeutic Proteins: It allows the mass production of safe, pure human proteins in bacterial or mammalian cell factories. Notable examples include human recombinant insulin, growth hormone, clotting factors (e.g., Factor VIII), and tissue plasminogen activator (tPA).

2. Vaccine Production: Production of subunit vaccines, such as the recombinant Hepatitis B vaccine and HPV vaccines, which are safer because they use cloned viral surface antigens instead of actual viral particles.

3. Medical Diagnosis: Detection of point mutations, diagnosis of genetic defects via RFLP, and identification of viral/bacterial pathogens (e.g., HIV, tuberculosis) using PCR and hybridization probes.

4. Gene Therapy: The treatment of genetic diseases by replacing or supplementing defective genes with normal, cloned genes. Vectors (like retroviruses, adenoviruses, or liposomes) deliver the functional gene ex vivo (to cultured patient cells that are returned to the body) or in vivo (directly into the patient).

5. Genome Editing: Novel techniques derived from recombinant DNA methods, such as the CRISPR-Cas9 system, allow highly specific RNA-targeted cleavage and precise editing of genomic DNA in vivo.